Ontology highlight
ABSTRACT: Materials and methods
The study included 129 patients with breast cancer. A microarray study of all tumour samples was carried out on microchips.Results
This study established that the presence of a deletion in genes ABCB1, ABCB4, ABCB8, ABCC7, ABCC11, ABCC12, ABCF2, and ABCG4 is associated with an objective response to treatment (p ≤ 0.05). A decrease in the expression of genes was associated with a good response to chemotherapy, whereas an increase in expression caused the progression and stabilization of the tumour. Analysis of metastatic-free survival rates showed that the presence of ABCB1/4 and ABCC1/6 deletions was associated with 100% survival (log-rank test p = 0.01 and p = 0.03).Conclusions
The study showed that the aberrant state of ABC transporter genes, as well as a decrease in the expression of these genes, is a predictor of the effectiveness of therapeutic treatment and a potential prognostic marker of metastatic survival.
SUBMITTER: Tsyganov MM
PROVIDER: S-EPMC9146568 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature

Tsyganov Matvey M MM Ibragimova Marina K MK Gaptulbarova Kseniya A KA Tsydenova Irina A IA Dolgasheva Daria S DS Garbukov Evgeniy Y EY Frolova Anastasia A AA Slonimskaya Elena M EM Litvyakov Nikolai V NV
Pharmaceutics 20220427 5
One of the important reasons for the ineffectiveness of chemotherapy in breast cancer (BC) is considered to be the formation of a multidrug resistance phenotype in tumour cells, which is caused by the expression of energy-dependent ABC transporters. The aim of this work was to assess chromosomal aberrations and the level of transcripts of all 49 known ABC transporter genes in breast tumours.<h4>Materials and methods</h4>The study included 129 patients with breast cancer. A microarray study of al ...[more]